These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35836236)

  • 21. CpG-Based Nanovaccines for Cancer Immunotherapy.
    Chen W; Jiang M; Yu W; Xu Z; Liu X; Jia Q; Guan X; Zhang W
    Int J Nanomedicine; 2021; 16():5281-5299. PubMed ID: 34385817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A General Strategy toward Self-assembled Nanovaccine Based on Cationic Lentinan to Induce Potent Humoral and Cellular Immune Responses.
    Yu R; Jin L; Song Z; Jiao L; Wang Z; Zhou Y; Ma Y; Guan S; Zhang Z; Wang D; Liu H; Sun Y; Zhang S; Cai T; Sun H; Qiu Y; Miao J; Liu Z
    Small; 2024 Oct; 20(43):e2402792. PubMed ID: 38940386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppressing Subcapsular Sinus Macrophages Enhances Transport of Nanovaccines to Lymph Node Follicles for Robust Humoral Immunity.
    Zhang YN; Poon W; Sefton E; Chan WCW
    ACS Nano; 2020 Aug; 14(8):9478-9490. PubMed ID: 32479046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2.
    Park KS; Bazzill JD; Son S; Nam J; Shin SW; Ochyl LJ; Stuckey JA; Meagher JL; Chang L; Song J; Montefiori DC; LaBranche CC; Smith JL; Xu J; Moon JJ
    J Control Release; 2021 Feb; 330():529-539. PubMed ID: 33358977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced Antitumor Immune Responses via a Self-Assembled Carrier-Free Nanovaccine.
    Liu D; Deng B; Liu Z; Ma B; Leng X; Kong D; Ji T; Liu L
    Nano Lett; 2021 May; 21(9):3965-3973. PubMed ID: 33886338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bidirectional and persistent immunomodulation of Astragalus polysaccharide as an adjuvant of influenza and recombinant SARS-CoV-2 vaccine.
    Zhao D; Chen X; Wang L; Zhang J; Zhao Z; Yue N; Zhu Y; Fei W; Li X; Tan L; He W
    Int J Biol Macromol; 2023 Apr; 234():123635. PubMed ID: 36801224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and immunological activity evaluation of an intranasal protein subunit vaccine against ancestral and mutant SARS-CoV-2 with curdlan sulfate/O-linked quaternized chitosan nanoparticles as carrier and adjuvant.
    Chen Y; Wang Y; Li Z; Jiang H; Pan W; Liu M; Jiang W; Zhang X; Wang F
    Int J Biol Macromol; 2024 Sep; 276(Pt 1):133733. PubMed ID: 39002905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyethylenimine-coated PLGA nanoparticles-encapsulated Angelica sinensis polysaccharide as an adjuvant for H9N2 vaccine to improve immune responses in chickens compared to Alum and oil-based adjuvants.
    Gu P; Wusiman A; Zhang Y; Cai G; Xu S; Zhu S; Liu Z; Hu Y; Liu J; Wang D
    Vet Microbiol; 2020 Dec; 251():108894. PubMed ID: 33096470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of a promising modular proteinaceous self-assembled delivery system for vaccination.
    Pan C; Ye J; Zhang S; Li X; Shi Y; Guo Y; Wang K; Sun P; Wu J; Wang H; Zhu L
    Nanoscale; 2023 Jun; 15(25):10794-10807. PubMed ID: 37326289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymph Node-Targeting Nanovaccine through Antigen-CpG Self-Assembly Potentiates Cytotoxic T Cell Activation.
    Xi X; Zhang L; Lu G; Gao X; Wei W; Ma G
    J Immunol Res; 2018; 2018():3714960. PubMed ID: 30018987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimalist Nanovaccine with Optimized Amphiphilic Copolymers for Cancer Immunotherapy.
    Niu L; Miao Y; Cao Z; Wei T; Zhu J; Li M; Bai B; Chen L; Liu N; Pan F; Zhu J; Wang C; Yang Y; Chen Q
    ACS Nano; 2024 Jan; 18(4):3349-3361. PubMed ID: 38230639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-Adjuvanted Molecular Activator (SeaMac) Nanovaccines Promote Cancer Immunotherapy.
    Luo Z; He T; Liu P; Yi Z; Zhu S; Liang X; Kang E; Gong C; Liu X
    Adv Healthc Mater; 2021 Apr; 10(7):e2002080. PubMed ID: 33336537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Influence of Adjuvant Type on the Immunogenicity of RBD/N Cocktail Antigens as a Vaccine Candidate against SARS-CoV-2 Virus.
    Brzuska G; Zimna M; Baranska K; Szewczyk B; Strakova P; Ruzek D; Krol E
    Microbiol Spectr; 2023 Jun; 11(3):e0256422. PubMed ID: 37199661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-like Receptor-4 (TLR4) Agonist-Based Intranasal Nanovaccine Delivery System for Inducing Systemic and Mucosal Immunity.
    Bakkari MA; Valiveti CK; Kaushik RS; Tummala H
    Mol Pharm; 2021 Jun; 18(6):2233-2241. PubMed ID: 34010002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines.
    Hu H; Yang C; Zhang F; Li M; Tu Z; Mu L; Dawulieti J; Lao YH; Xiao Z; Yan H; Sun W; Shao D; Leong KW
    Adv Sci (Weinh); 2021 Aug; 8(15):2002020. PubMed ID: 34386315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection.
    Zhong L; Zhang W; Liu H; Zhang X; Yang Z; Wen Z; Chen L; Chen H; Luo Y; Chen Y; Feng Q; Zeng MS; Zhao Q; Liu L; Krummenacher C; Zeng YX; Chen Y; Xu M; Zhang X
    Nat Commun; 2024 Jun; 15(1):5310. PubMed ID: 38906867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-Assembling Sulfated
    Zhang S; Fan W; Ding C; Zhang M; Liu S; Liu W; Tang Z; Huang C; Yan L; Song S
    ACS Appl Mater Interfaces; 2024 Apr; 16(15):18591-18607. PubMed ID: 38564431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monophosphoryl lipid A-assembled nanovaccines enhance tumor immunotherapy.
    Li R; Hao Y; Pan W; Wang W; Min Y
    Acta Biomater; 2023 Nov; 171():482-494. PubMed ID: 37708924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-adjuvant multiepitope nanovaccine based on ferritin induced long-lasting and effective mucosal immunity against H3N2 and H1N1 viruses in mice.
    Nie J; Zhou Y; Ding F; Liu X; Yao X; Xu L; Chang Y; Li Z; Wang Q; Zhan L; Zhu L; Xie K; Li C; Shi Y; Zhao Q; Shan Y
    Int J Biol Macromol; 2024 Feb; 259(Pt 1):129259. PubMed ID: 38191112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Immunoenhancement Effects of Polyethylenimine-Modified Chinese Yam Polysaccharide-Encapsulated PLGA Nanoparticles as an Adjuvant.
    Zhang Y; Gu P; Wusiman A; Xu S; Ni H; Qiu T; Liu Z; Hu Y; Liu J; Wang D
    Int J Nanomedicine; 2020; 15():5527-5543. PubMed ID: 32848386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.